Is ZHUD or JNJ a better dividend investment in 2026?

ZHUD currently yields 20408.16% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: ZHUD offers higher current income.

What is the dividend yield difference between ZHUD and JNJ?

ZHUD has a forward dividend yield of 20408.16% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 20406.03 percentage points.

Home › Compare › ZHUD vs JNJ

ZHUD vs JNJ: Dividend Comparison 2026

ZHUD yields 20408.16% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZHUD wins by $64137456153342001152.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZHUD

● Live price

20408.16%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$64137456153342001152.00M

Annual income

$63,525,134,733,775,620,000,000,000.00

Full ZHUD calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — ZHUD vs JNJ

📍 ZHUD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZHUD	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZHUD + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZHUD pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZHUD

Annual income on $10K today (after 15% tax)

$1,734,693.88/yr

After 10yr DRIP, annual income (after tax)

$53,996,364,523,709,275,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, ZHUD beats the other by $53,996,364,523,709,275,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZHUD + JNJ for your $10,000?

ZHUD: 50%JNJ: 50%

100% JNJ50/50100% ZHUD

Portfolio after 10yr

$32068728076671000576.00M

Annual income

$31,762,567,366,887,810,000,000,000.00/yr

Blended yield

99.05%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ZHUD

No analyst data

Altman Z

4.3

Piotroski

6/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZHUD buys

JNJ buys

Politician	Chamber	Ticker	Type	Amount	Date
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2026-01-23
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-12-18
Lloyd Doggett	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-12-09
Thomas H. Kean	🏢 House	$JNJ	▼ Sell	$15,001 - $50,000	2025-11-20
Julie Johnson	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-11-13
Rich McCormick	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-11-05
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Ro Khanna	🏢 House	$JNJ	▲ Buy	$1,001 - $15,000	2025-10-30
Jared Moskowitz	🏢 House	$JNJ	▼ Sell	$1,001 - $15,000	2025-10-10

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZHUDJNJ

Forward yield	20408.16% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$64137456153342001152.00M ✓	$30.3K
Annual income after 10y	$63,525,134,733,775,620,000,000,000.00 ✓	$4,689.40
Total dividends collected	$64097060870337249280.00M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ZHUD vs JNJ ($10,000, DRIP)

Year	ZHUD Portfolio	ZHUD Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$2,051,516	$2,040,816.33	$10,592	$272.30	+$2.04M → ZHUD
2	$393,481,853	$391,286,730.22	$11,289	$357.73	+$393.47M → ZHUD
3	$70,560,268,237	$70,139,242,654.99	$12,123	$472.89	+$70560.26M → ZHUD
4	$11,830,233,600,282	$11,754,734,113,267.86	$13,141	$629.86	+$11830233.59M → ZHUD
5	$1,854,541,731,801,032	$1,841,883,381,848,729.50	$14,408	$846.81	+$1854541731.79M → ZHUD
6	$271,833,874,765,240,000	$269,849,515,112,212,900.00	$16,021	$1,151.60	+$271833874765.22M → ZHUD
7	$37,257,064,005,127,240,000	$36,966,201,759,128,440,000.00	$18,122	$1,588.22	+$37257064005127.23M → ZHUD
8	$4,774,931,791,663,175,000,000	$4,735,066,733,177,689,000,000.00	$20,930	$2,228.20	+$4774931791663175.00M → ZHUD
9	$572,263,008,940,552,750,000,000	$567,153,831,923,473,140,000,000.00	$24,792	$3,191.91	+$572263008940552768.00M → ZHUD
10	$64,137,456,153,342,000,000,000,000	$63,525,134,733,775,620,000,000,000.00	$30,274	$4,689.40	+$64137456153342001152.00M → ZHUD

ZHUD vs JNJ: Complete Analysis 2026

ZHUD — Stock

Zhuding International Limited, through its subsidiary, Fujian Zhuding Building Materials Co. Ltd, manufactures and sells building materials in China. Its products include wall panels and precast panels. The company was formerly known as Van Gold Resources, Inc. and changed its name to Zhuding International Limited in July 2016. Zhuding International Limited was founded in 2006 and is based in Fuzhou, China.

Full ZHUD Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this ZHUD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZHUD vs SCHD ZHUD vs JEPI ZHUD vs O ZHUD vs KO ZHUD vs MAIN ZHUD vs ABBV ZHUD vs MRK ZHUD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.